Mediclinic City Hospital’s Comprehensive Cancer Centre (CCC), is Dubai’s most advanced facility for the diagnosis and treatment of cancer.

Mediclinic City Hospital’s Comprehensive Cancer Centre (CCC), is Dubai’s most advanced facility for the diagnosis and treatment of cancer.

Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC benefit from the sharing of knowledge and experience between some of the leading oncology experts in Europe and the Middle East, as well as access to the very latest treatment programmes and technology.

Scope of service

The CCC is the first centre of its kind in Dubai to combine diagnostic procedures with the treatment modalities of surgery, medical oncology and radiation therapy. The range of services ensures the very highest levels of care for cancer patients. Services at the core of the CCC include:

  • Medical Oncology (including chemotherapy, immunotherapy and endocrine therapy)
  • Radiotherapy (with TrueBeam linear accelerator and CT Simulator)
  • Surgical Oncology
  • Radiology (breast cancer diagnostic imaging programme)
  • Nuclear Medicine (diagnostic and therapeutic service including PET & SPECT CT, automated injector/FDG)
  • Reference Laboratory
  • Specialised pharmacy for chemotherapy
  • Supportive Care (psychological support, physiotherapy, nutrition and Pain Clinic)

Conditions and sites treated include all types of adult and paediatric cancers for both male and female patients, with following being the most frequent ones:

  • Breast tumours
  • Gynaecological cancers (ovarian, endometrial and cervical)
  • Lung tumours (bronchial and lung)
  • Gastrointestinal tumours (oesophageal, gastric, colo-rectal and pancreatic)
  • Renal and genito-urinary tract, prostate and testicular tumours
  • Head and neck tumours (brain)
  • Neuro-endocrine tumours (thyroid and adrenal)
  • Soft tissue tumours (sarcomas)
  • Blood, bone marrow and lymphatic system tumours (lymphomas, myelomas & leukaemia)
  • Palliative (pain control, bone metastases)
  • Emergencies (spinal cord compression and supra vena cava obstruction-SVCO, uncontrolled tumour haemorrhage)

Tumour boards

The CCC practises a multidisciplinary approach to cancer care and has established tumour boards of various medical disciplines, including surgeons, oncologists, radiation oncologists, consultants and specialists doctors, all of whom, together, decide on a personalised course of treatment, following international up to date guidelines.

Collaboration disciplines include:

  • Internal Medicine
  • Pharmacy
  • General/Cancer Surgery
  • Gynecology/Surgery
  • Gastroenterology/Abdominal Surgery
  • Pulmonology/Thoracic Surgery
  • Cardiology/Cardiac Surgery
  • Urology/Urological Surgery
  • Neurology and Neuro Surgery
  • Breast and Reconstruction Surgery
  • Psycho-oncology
  • Dietetics
  • Physiotherapy
  • Social Services


The CCC is housed in Mediclinic City Hospital’s newly constructed North Wing extension, located directly opposite the hospital next to Dubai Healthcare City metro station. Facilities include:

  • Eight consultation rooms
  • Two bunkers for Linacs
  • 11 cubicles for chemotherapy
  • Radiology facility
  • Nuclear Medicine facility
  • MTD room with modern videoconferencing for tumour board meetings

State-of-the-art, cutting edge technology

The CCC is equipped with a TrueBeam linear accelerator for radiation therapy. It is the first in the UAE, offering the newest treatment technology of flattening filter free energy, and the only Varian 13.7 version in the MENA region. The TrueBeam treats patients using the latest cutting edge technology modalities for malignant and benign tumours:

  • Conformal radiotherapy - CRT
  • Intensity modulated radiotherapy - IMRT
  • Volumetric modulated arc therapy - VMAT
  • RAPID Arc technology
  • Stereotactic radio surgery - SRS
  • Stereotactic body radiotherapy - SBRT
  • Respiratory gating technology - RPM
  • Brachytherapy

The TrueBeam data is matched to that at Hirslanden in Switzerland, Mediclinic Middle East’s sister platform and partner in the CCC project, as well as international published data and Varian standard data with a variation of less than 0.5%. This technology matching means that it is possible for a patient to be treated at both the CCC at Mediclinic City Hospital in Dubai, or at Hirslanden in Switzerland, without the need for dose recalculations.


The CCC is accredited along with Mediclinic City Hospital by Joint Commission International (JCI).